NewsStocks Sanofi To Acquire Inhibrx in $1.7 Billion Deal To Boost Rare Disease Drugs Pipeline by admin 23/01/2024 23/01/2024 KEY TAKEAWAYS Sanofi is buying Inhibrx in a $1.7 billion deal as the French pharmaceutical … 0 FacebookTwitterPinterestEmail
